MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, Ronald B., Berg, Daniela, Stern, Matthew, Poewe, Werner, Olanow, C. Warren, Oertel, Wolfgang, Obeso, José, Marek, Kenneth +10 more·2015·Movement Disorders

DOI 10.1002/mds.26424

Cited by (1,019)

Items 701–800 of 1,019

From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease
Ambra Stefani, Elena Antelmi, Dario Arnaldi, Isabelle Arnulf, Emmanuel During, Birgit Högl, Michele M. T. Hu, Álex Iranzo, Russell Luke, John H. Peever et al. · 2025 · Molecular Neurodegeneration
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
Rizwan S. Akhtar, Sharon Xiangwen Xie, Yin J. Chen, Jacqueline H. Rick, Rachel G. Gross, Ilya M. Nasrallah, Vivianna M. Van Deerlin, John Q. Trojanowski, Alice S. Chen‐Plotkin, Howard I. Hurtig et al. · 2017 · PLoS ONE
An update on the genetics of dementia with Lewy bodies
Leonie J.M. Vergouw, Inger van Steenoven, Wilma D. J. van de Berg, Charlotte Elisabeth Teunissen, John Cornelis Van Swieten, Vincenzo Bonifati, Afina Willemina Lemstra, Frank Jan de Jong · 2017 · Parkinsonism & Related Disorders
Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases
Soichiro Shimizu, Daisuke Hirose, Hirokuni Hatanaka, Naoto Takenoshita, Yoshitsugu Kaneko, Yusuke Ogawa, Hirofumi Sakurai, Haruo Hanyu · 2018 · Frontiers in Neurology
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective
Stéphane Thobois, Stéphane Prange, Christian Scheiber, Emmanuel Broussolle · 2018 · Parkinsonism & Related Disorders
White matter differences between essential tremor and Parkinson disease
Meher R. Juttukonda, Giulia Franco, Dario J. Englot, Ya‐Chen Lin, Kalen J. Petersen, Paula Trujillo, Peter Hedera, Bennett A. Landman, Hakmook Kang, Manus Joseph Donahue et al. · 2018 · Neurology
Use of Magnetic Resonance Imaging and Artificial Intelligence in Studies of Diagnosis of Parkinson’s Disease
Jingjing Xu, Minming Zhang · 2019 · ACS Chemical Neuroscience
Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes
Ralph Buchert, Carsten Buhmann, Ivayla Ilieva Apostolova, Philipp Tobias Meyer, Jürgen Gallinat · 2019 · Deutsches Ärzteblatt international
Organochlorine pesticide levels in Greek patients with Parkinson’s disease
Efthimios Dardiotis, Athina‐Maria Aloizou, Evagelos Sakalakis, Vasileios Siokas, Michalis Koureas, Georgia Xiromerisiou, Efthymia A. Petinaki, Martin F. Wilks, Aristidis Michael Tsatsakis, Christos S. Hadjichristodoulou et al. · 2020 · Toxicology Reports
Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease
Yanmei Chen, Jingxue Zheng, Lufen Su, Fengxian Chen, Ruihan Zhu, Xiaochun Chen, Qinyong Ye · 2020 · Frontiers in Aging Neuroscience
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study
Andrea Quattrone, Angelo Antonini, David E. Vaillancourt, Klaus Seppi, Roberto Ceravolo, Antonio P. Strafella, Maurizio Morelli, Salvatore Lo Nigro, Basilio Vescio, Maria Giovanna Bianco et al. · 2020 · Movement Disorders
Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body Dementias
Howard, Erica, Irwin, David J., Rascovsky, Katya, Nevler, Naomi, Shellikeri, Sanjana, Tropea, Thomas F., Spindler, Meredith, Deik, Andres, Chen-Plotkin, Alice, Siderowf, Andrew et al. · 2021 · Neurology
Morphological basis of Parkinson disease-associated cognitive impairment: an update
K. A. Jellinger · 2022 · Journal of Neural Transmission
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Youssef, Priscilla, Hughes, Laura, Kim, Woojin S., Halliday, Glenda M., Lewis, Simon J. G., Cooper, Antony, Dzamko, Nicolas · 2023 · Scientific Reports
Transcriptomic profiles in Parkinson’s disease
Lille Kurvits, Freddy Lättekivi, Ene Reimann, Liis Kadastik‐Eerme, Kristjan M. Kasterpalu, Sulev Kõks, Pille Taba, Anu Planken · 2020 · Experimental Biology and Medicine
Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus
Nicoló Gabriele Pozzi, Joachim Brumberg, Massimiliano Todisco, Brigida Minafra, Roberta Zangaglia, Irene Bossert, Giuseppe Trifirò, Roberto Ceravolo, Paolo Vitali, Ioannis U. Isaias et al. · 2020 · Movement Disorders
Differential diagnosis of parkinsonism based on deep metabolic imaging indices
Ping Wu, Yu Shan Zhao, Jianjun Wu, Matthias Brendel, Jiaying Lu, Jingjie Ge, Alexander Maximilian Bernhardt, Ling Li, Ian Alberts, Sabrina Katzdobler et al. · 2022 · Journal of Nuclear Medicine
Autopsy Validation of the Diagnostic Accuracy of 123 I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
Tomoyasu Matsubara, Masashi Kameyama, Noriko Tanaka, Renpei Sengoku, Makoto Orita, Ko Furuta, Atsushi Iwata, Tomio Arai, Hirofumi Maruyama, Yuko Saito et al. · 2022 · Neurology
Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study
Yuanyuan Li, Yan Yang, Aonan Zhao, Ningdi Luo, Mengyue Niu, Wenyan Kang, Anmu Xie, Hong Lu, Lei Chen, Jun Liu · 2022 · Journal of Neuroinflammation
Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease
María Teresa Periñán, Daniel Macías‐García, Silvia Jesús, Juan Francisco Martin‐Rodríguez, Laura Muñoz‐Delgado, María Valle Jiménez‐Jaraba, Dolores Buiza‐Rueda, Marta Bonilla‐Toribio, Astrid Daniela Adarmes-Gómez, Pilar Gómez‐Garre et al. · 2022 · Journal of Neurology
METTL14 is decreased and regulates m 6 A modification of α‐synuclein in Parkinson's disease
Honghu He, Qinxin Zhang, Jiajia Liao, Jiang Lei, Man Luo, Jianyi Huang, Meiling Chen, Yuefei Shen, Jin Wang, Pingyi Xu et al. · 2023 · Journal of Neurochemistry
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years
Stefanie Theresa Jost, Salima Aloui, Julian Evans, Keyoumars Ashkan, Anna Sauerbier, Alexandra Rizos, Jan Niklas Petry‐Schmelzer, Alexandra Gronostay, Gereon R. Fink, Veerle E. R. M. Visser-Vandewalle et al. · 2024 · JAMA Network Open
Deep learning predicts prevalent and incident Parkinson’s disease from UK Biobank fundus imaging
Charlie Tran, Kai Shen, Kang Liu, Akshay Ashok, Adolfo Ramirez‐Zamora, Jinghua Chen, Yulin Li, Ruogu Fang · 2024 · Scientific Reports
Altered Kinematics of Facial Emotion Expression and Emotion Recognition Deficits Are Unrelated in Parkinson’s Disease
Matteo Bologna, Isabella Berardelli, Giulia Paparella, Luca Marsili, Lucia Ricciardi, Giovanni Fabbrini, Alfredo Berardelli · 2016 · Frontiers in Neurology
The Motor Syndrome of Parkinson's Disease
Roberto Erro, María Stamelou · 2017 · International review of neurobiology
Retinal changes in Parkinson's disease and glaucoma
Juliane Matlach, Martin Wagner, Uwe Malzahn, Irene M. Schmidtmann, Frank Steigerwald, Thomas Musacchio, Jens Volkmann, Franz J. Grehn, Winfried Göbel, Stephan Klebe · 2018 · Parkinsonism & Related Disorders
Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension
Luis E. Okamoto, Cyndya A. Shibao, Alfredo C. Gamboa, André Diedrich, Satish R. Raj, Bonnie K. Black, David Robertson, Italo Biaggioni · 2018 · Hypertension
Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease
Laura Pelizzari, Maria Marcella Laganà, Federica Rossetto, Niels Bergsland, M Galli, Giuseppe Baselli, Mario Clerici, Raffaello Nemni, Francesca Baglio · 2019 · Therapeutic Advances in Neurological Disorders
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus‐like magnetic resonance imaging features
Masahiro Ohara, T. Hattori, Takanori Yokota · 2020 · European Journal of Neurology
Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses
Takayuki Katayama, Jun Sawada, Kae Takahashi, Osamu Yahara · 2020 · Brain Sciences
Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease
Eric Yu, Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Mehrdad A. Estiar, Dan Spiegelman, Matthew Surface, Stanley Fahn et al. · 2020 · Movement Disorders
Different Perivascular Space Burdens in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
Xiaoli Si, Luyan Gu, Zhe Song, Cheng Zhou, Yi Fang, Chongyao Jin, Jingjing Wu, Ting Gao, Tao Guo, Xiaojun Guan et al. · 2020 · Frontiers in Aging Neuroscience
Emerging concepts on bradykinesia in non‐parkinsonian conditions
Giulia Paparella, Alfonso A. Fasano, Mark Hallett, Alfredo Berardelli, Matteo Bologna · 2021 · European Journal of Neurology
Progression in Parkinson's Disease: Variation in Motor and Non‐motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health‐Related Quality of Life as Assessed by Two Different Methods
Paulo Bugalho, Filipa Freitas Ladeira, Raquel Pinheiro Barbosa, João Pedro Marto, Cláudia Borbinha, Laurete da Conceição, Manuel Salavisa, Marlene Saraiva, Bruna Meira, Marco Fernandes · 2021 · Movement Disorders Clinical Practice
Alpha-Synuclein and Cognitive Decline in Parkinson Disease
Tian-Sin Fan, Sam Chi-Hao Liu, Ruey‐Meei Wu · 2021 · Life
Remote Evaluation of Parkinson's Disease Using a Conventional Webcam and Artificial Intelligence
Mariana H.G. Monje, Sergio Domínguez, Javier Vera-Olmos, Angelo Antonini, Tiago Mestre, Norberto Malpica, Álvaro Sánchez‐Ferro · 2021 · Frontiers in Neurology
Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again
Yaroslau Compta, Cèlia Painous, Marta Soto, Marta Pulido-Salgado, Manel Fernández, Ana Cámara, V. Sánchez, Núria Bargalló, Nuria Suelves Caballol, Claustre Pont‐Sunyer et al. · 2022 · Parkinsonism & Related Disorders
Pharmacological effects of Eleutherococcus senticosus on the neurological disorders
Xi‐Tao Li, Jie‐Chun Zhou, Yu Jerry Zhou, Ying‐Shan Ren, Yu‐Hong Huang, Shumei Wang, Long Tan, Zhiyou Yang, Yue‐Wei Ge · 2022 · Phytotherapy Research
Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
Michele Salemi, Giovanna Marchese, Giuseppe Lanza, F. Cosentino, Maria Grazia Salluzzo, Francesca A. Schillaci, Giovanna Maria Ventola, Angela Cordella, Maria Ravo, Raffaele Ferri · 2022 · International Journal of Molecular Sciences
Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”
Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, Johannes Attems, Vincenzo Bonifati, Francisco Cardoso, Marie‐Françoise Chesselet, John Hardy, Graziella Madeo, Ian Grant McKeith et al. · 2023 · Movement Disorders
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara · 2023 · Brain Sciences
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA -associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
Fabiana Colucci, Micol Avenali, Rosa De Micco, Marco Fusar Poli, Silvia Cerri, Mario Stanziano, Ana Bacila, Giada Cuconato, Valentina Franco, Diego M Franciotta et al. · 2023 · BMJ Neurology Open
Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies
Irene Frigerio, Maud M. A. Bouwman, Ruby T G M M Noordermeer, Ema Podobnik, Marko M. Popovic, Evelien Timmermans, Annemieke J.M. Rozemüller, Wilma D. J. van de Berg, Laura E. Jonkman · 2024 · Acta Neuropathologica Communications
Synaptic loss and its association with symptom severity in Parkinson’s disease
Sophie E. Holmes, Praveen Honhar, Sule Tinaz, Mika Naganawa, Ansel T. Hilmer, Jean‐Dominique Gallezot, Mark Dias, Yanghong Yang, Takuya Toyonaga, Irina Esterlis et al. · 2024 · npj Parkinson s Disease
Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort
Sebastian Schade, Friederike Sixel‐Döring, Jens Ebentheuer, Xenia Schulz, Claudia Trenkwalder, Brit Mollenhauer · 2017 · Movement Disorders Clinical Practice
Distinct alterations in Parkinson's medication-state and disease-state connectivity
Bernard Ng, Gael P. Varoquaux, Jean‐Baptiste Poline, Bertrand Thirion, Michael D. Greicius, Kathleen L. Poston · 2017 · NeuroImage Clinical
Autonomic dysfunction in Parkinson disease and animal models
Jeanette M. Metzger, Marina Elena Emborg · 2019 · Clinical Autonomic Research
Non-motor symptoms in Huntington’s disease: a comparative study with Parkinson’s disease
Tatiana Aldaz, Pasquale Nigro, Almudena Sánchez‐Gómez, Cèlia Painous, Lluís Planellás, Pilar Santacruz, Ana Cámara, Yaroslau Compta, Francesc Valldeoriola, Marı́a José Martı́ et al. · 2019 · Journal of Neurology
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indices
Nicolas Nicastro, Jennifer Wegrzyk, Maria Giulia Preti, Vanessa Fleury, Dimitri Van De Ville, Valentina Garibotto, Pierre R. Burkhard · 2019 · Journal of Neurology
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study
Andrea Pilotto, Francesca Schiano di Cola, Enrico Premi, Roberto Grasso, Rosanna Turrone, Stefano Gipponi, Andrea Scalvini, Elisabetta Cottini, Barbara Paghera, Valentina Garibotto et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
Spreading of alpha‐synuclein – relevant or epiphenomenon?
Bryan A. Killinger, Jeffrey H. Kordower · 2019 · Journal of Neurochemistry
Simultaneous tonic and phasic REM sleep without atonia best predicts early phenoconversion to neurodegenerative disease in idiopathic REM sleep behavior disorder
Jiří Nepožitek, Simona Dostálová, Petr Dušek, David Kemlink, Iva Příhodová, Veronika Ibarburu Lorenzo y Losada, Latica Friedrich, Ondřej Bezdíček, Tomáš Nikolai, Pavla Peřinová et al. · 2019 · SLEEP
Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis
Wang, Qian, Liu, Jianfang, Guo, Yikun, Dong, Guanzhong, Zou, Wenying, Chen, Zhuoyou · 2019 · Brazilian Journal of Medical and Biological Research
Muscle Synergies in Parkinson’s Disease
Ilaria Mileti, Alessandro Zampogna, Alessandro Santuz, Francesco Asci, Zaccaria Del Prete, Adamantios Arampatzis, Eduardo Palermo, Antonio Suppa · 2020 · Sensors
Validation of the Neurogenic Orthostatic Hypotension Ratio with Active Standing
Alessandra Fanciulli, Katharina Kerer, Fabian Leys, Klaus Seppi, Horacio Kaufmann, Lucy Norcliffe‐Kaufmann, Gregor Karl Wenning · 2020 · Annals of Neurology
Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease
Ewa Papuć, Konrad Rejdak · 2020 · Frontiers in Aging Neuroscience
α-Synuclein Overexpression Induces Lysosomal Dysfunction and Autophagy Impairment in Human Neuroblastoma SH-SY5Y
Ana Carolina Nascimento, Adolfo Garcia Erustes, Patrícia Reckziegel, Cláudia Bincoletto, Rodrigo Portes Ureshino, Gustavo J.S. Pereira, Soraya Soubhi Smaili · 2020 · Neurochemical Research
Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's Disease
Rick C. G. Helmich, Kevin R.E. van den Berg, Pattamon Panyakaew, Hyun J. Cho, Thomas Osterholt, Patrick M. McGurrin, Ejaz A. Shamim, Traian Popa, Dietrich Haubenberger, Mark Hallett · 2021 · Movement Disorders
Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer.
Zhong-Ci Hang, Tong Lei, Ze-Hua Zeng, Shang-Lin Cai, Wang-Yu Bi, Hongwu Du · 2021 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Parkinson Disease Overview
Lola P. Cook, Jeanine Schulze, Janice L. Farlow, Nathan Pankratz, Joanne Wojcieszek, Tatiana Foroud · 2014 · Europe PMC (PubMed Central)
Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study
Alan J. Thomas, John‐Paul Taylor, Ian Grant McKeith, Claire H. Bamford, David John Burn, Louise M. Allan, John Tiernan O'Brien · 2018 · International Journal of Geriatric Psychiatry
Large-scale network dysfunction in α-Synucleinopathy: A meta-analysis of resting-state functional connectivity
Shi Tang, Yanlin Wang, Yaping Liu, Steven Wai Ho Chau, Joey Wing Yan Chan, Chiu‐Wing Winnie Chu, Jill Abrigo, Vincent Mok, Yun Kwok Wing · 2022 · EBioMedicine
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
Matteo Conti, Roberta Bovenzi, Elena Garasto, Tommaso Schirinzi, Fabio Placidi, Nicola Biagio Mercuri, Rocco Cerroni, Mariangela Pierantozzi, Alessandro Stefani · 2022 · Frontiers in Neurology
Mass Spectrometry-Based Analysis of Serum N-Glycosylation Changes in Patients with Parkinson’s Disease
Mingming Xu, Hong Jin, Zhen Wu, Ying Han, Jing Chen, Chengjie Mao, Piliang Hao, Xumin Zhang, Chun‐Feng Liu, Shuang Yang · 2022 · ACS Chemical Neuroscience
Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
Michal Novotný, Tereza Tykalová, Hana Růžičková, Evžen Růžička, Petr Dušek, Jan Rusz · 2022 · npj Digital Medicine
Effect of acupuncture for non-motor symptoms in patients with Parkinson’s disease: A systematic review and meta-analysis
Qinglian Li, Chunxiao Wu, Xiaoling Wang, Zhen Li, Xiaoqian Hao, Lijun Zhao, Mengzhu Li, Meiling Zhu · 2022 · Frontiers in Aging Neuroscience
Multilingual evaluation of interpretable biomarkers to represent language and speech patterns in Parkinson's disease
Anna Favaro, Laureano Moro-Velázquez, Ankur Butala, Chelsie Motley, Tianyu Cao, Robert David Stevens, Jesús Villalba, Najim Dehak · 2023 · Frontiers in Neurology
IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice
Min Cao, Jing Liu, Xiaomin Zhang, Yaqi Wang, Yuli Hou, Qiao Song, Yuting Cui, Yue Zhao, Peichang Wang · 2023 · Immunity & Ageing
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Bram van der Gaag, Natasja A. C. Deshayes, John J. P. Brevé, John G. J. M. Bol, Allert J. Jonker, Jeroen J.M. Hoozemans, Jean‐Philippe Courade, Wilma D. J. van de Berg · 2024 · Acta Neuropathologica
Multi-night cortico-basal recordings reveal mechanisms of NREM slow-wave suppression and spontaneous awakenings in Parkinson’s disease
Md Fahim Anjum, Clay N Smyth, José Rafael P. Zuzuárregui, Derk‐Jan Dijk, Philip A. Starr, Timothy Denison, Simon J Little · 2024 · Nature Communications
Baseline motor findings and Parkinson disease prognostic subtypes
Ali H. Rajput, Michele L. Rajput, Leslie Wayne Ferguson, Alex H. Rajput · 2017 · Neurology
Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis
Azin Shafieesabet, Seyed‐Mohammad Fereshtehnejad, Azadeh Shafieesabet, Ahmad Delbari, Hamid Reza Baradaran, Ronald B. Postuma, Johan Lökk · 2017 · Parkinsonism & Related Disorders
Changes in Cortical Thickness in Patients With Early Parkinson’s Disease at Different Hoehn and Yahr Stages
Yuyuan Gao, Kun Nie, Mingjin Mei, Manli Guo, Zhiheng Huang, Limin Wang, Jiehao Zhao, Biao Huang, Yuhu Zhang, Lijuan Wang · 2018 · Frontiers in Human Neuroscience
Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson’s Disease: A Potential Disease Biomarker
Zhaofei Yang, Tianbai Li, Yanhua Cui, Song Li, Cheng Cheng, Bairong Shen, Weidong Le · 2019 · Frontiers in Neuroscience
Biomarkers of Parkinson’s disease: 20 years later
Rezzak Yılmaz, Franziska Hopfner, Thilo van Eimeren, Daniela Berg · 2019 · Journal of Neural Transmission
Structural Imaging in Parkinson’s Disease: New Developments
Stéphane Prange, Élise Météreau, Stéphane Thobois · 2019 · Current Neurology and Neuroscience Reports
Raman profiling of circulating extracellular vesicles for the stratification of Parkinson’s patients
Alice Gualerzi, Silvia Picciolini, Cristiano Carlomagno, Federica Terenzi, Silvia Ramat, Sandro Sorbi, Marzia Bedoni · 2019 · Nanomedicine Nanotechnology Biology and Medicine
The therapeutic potential of exercise for neuropsychiatric diseases: A review
Sabrina Swenson, Kenneth Blum, Thomas McLaughlin, Mark S. Gold, Panayotis K. Thanos · 2020 · Journal of the Neurological Sciences
Visual self-motion cues are impaired yet overweighted during visual–vestibular integration in Parkinson’s disease
Sol Yakubovich, Simon Israeli‐Korn, Orly Halperin, Gilad Yahalom, Sharon Hassin‐Baer, Adam Zaidel · 2020 · Brain Communications
Structural and Functional Thalamic Changes in Parkinson's Disease With Mild Cognitive Impairment
Mingge Li, Jianfeng He, Xin‐yun Liu, Zhen‐fu Wang, Xin Lou, Lin Ma · 2020 · Journal of Magnetic Resonance Imaging
Parkinson’s disease detection from 20-step walking tests using inertial sensors of a smartphone: Machine learning approach based on an observational case-control study
Milla Juutinen, Cassia Wang, Justin Xi Zhu, Juan Haladjian, Jari Ruokolainen, Juha Puustinen, Antti T. Vehkaoja · 2020 · PLoS ONE
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus
Ting Wang, Feilan Yuan, Zhenze Chen, Shuzhen Zhu, Zihan Chang, Wanlin Yang, Bin Deng, Rongfang Que, Peihua Cao, Yinxia Chao et al. · 2020 · Aging
Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease
Prabhjyot Saini, Uladzislau Rudakou, Eric Yu, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Stanley Fahn, Cheryl Waters, Oury Monchi et al. · 2020 · Neurobiology of Aging
Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden
Hannah von Eichel, Johanne Heine, Florian Wegner, Sophia Rogozinski, Stephanie Stiel, Adrian Groh, Lea Krey, Günter U. Höglinger, Martin Klietz · 2022 · Brain Sciences
Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6/JAK2/STAT3 Pathway in Parkinson’s Disease Model
Xueping Yang, Qingyun Yv, Fanlong Ye, Sheng Chen, Zhang He, Wenwei Li, Fang Dong · 2022 · Frontiers in Pharmacology
Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson’s disease, especially on bradykinesia
Liu, Huijing, Su, Wen, Li, Shuhua, Du, Wei, Ma, Xinxin, Jin, Ying, Li, Kai, Chen, Haibo · 2017 · Clinical Neurology and Neurosurgery
Characterization of gait variability in multiple system atrophy and Parkinson’s disease
Victoria Sidoroff, Cecilia Raccagni, Christine Kaindlstorfer, Sabine Eschlboeck, Alessandra Fanciulli, Roberta Granata, Bjoern M. Eskofier, Klaus Seppi, Werner H Poewe, Johann Willeit et al. · 2020 · Journal of Neurology
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
Valeria Conti, Viviana Izzo, Maria Claudia Russillo, Marina Picillo, Marianna Amboni, Cesa Lorella Maria Scaglione, Alessandra Susie Quesado Nicoletti, Ilaria Cani, Calogero Edoardo Cicero, Emanuela De Bellis et al. · 2022 · Frontiers in Medicine
Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders
Elon D. Wallert, Elsmarieke van de Giessen, Remco J.J. Knol, Martijn Beudel, Rob M. A. de Bie, Jan Booij · 2022 · Journal of Nuclear Medicine
An Analysis of Vocal Features for Parkinson’s Disease Classification Using Evolutionary Algorithms
Son Vu Truong Dao, Zhiqiu Yu, Ly Van Tran, Phuc N. K. Phan, Tri Huynh, Tuan Minh Le · 2022 · Diagnostics
Neuroprotective Effects of Lactoferrin in Alzheimer’s and Parkinson’s Diseases: A Narrative Review
Shin Jie Yong, Abhi Veerakumarasivam, Wei Ling Lim, Jactty Chew · 2023 · ACS Chemical Neuroscience
MerTK is a mediator of alpha-synuclein fibril uptake by human microglia
Marie‐France Dorion, Moein Yaqubi, Konstantin A. Senkevich, Nicholas W. Kieran, Adam MacDonald, Carol X.‐Q. Chen, Wen Luo, Amber Wallis, Irina Shlaifer, Jeffery Alan Hall et al. · 2023 · Brain
Noradrenergic alterations in Parkinson’s disease: a combined 11C-yohimbine PET/neuromelanin MRI study
Chloé Laurencin, Sophie Lancelot, Sarah Brosse, Inès Mérida, Jérôme Redouté, Elise Greusard, Ludovic Lamberet, Véronique Liotier, Didier Le Bars, Nicolas Costes et al. · 2023 · Brain
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease
Eleonora Fiorenzato, Sadaf Moaveninejad, Luca Weis, Roberta Biundo, Angelo Antonini, Camillo Porcaro · 2023 · Movement Disorders
Digital Mobility Measures: A Window into Real‐World Severity and Progression of Parkinson's Disease
Anat Mirelman, Jana Volkov, Amit Salomon, Eran Gazit, Alice Nieuwboer, Lynn Rochester, Silvia Del Din, Laura Avanzino, Elisa Pelosin, Bastiaan R. Bloem et al. · 2023 · Movement Disorders
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l ‐ DOPA treatment and changes in levodopa‐induced dyskinesia
Andreas Dammann Andersen, Morten Blaabjerg, Michael Binzer, Akram Kamal, Helle Thagesen, Troels W. Kjær, Egon Stenager, Jan Bert Gramsbergen · 2017 · Journal of Neurochemistry
Recognizing Atypical Parkinsonisms: “Red Flags” and Therapeutic Approaches
Christopher W. Hess, Nikolaus R. McFarland · 2017 · Seminars in Neurology
Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients
Michael Sommerauer, Allan K. Hansen, Peter Parbo, Tatyana Dmitrievna Fedorova, Karoline Knudsen, Yoon Frederiksen, Adjmal Nahimi, Michael T. Barbe, David James Brooks, Per Borghammer · 2018 · Movement Disorders
Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis
Hirohisa Watanabe, Yuichi Riku, Kazuhiro Hara, Kazuya Kawabata, Tomohiko Nakamura, Mizuki Ito, Masaaki Hirayama, Mari Yoshida, Masahisa Katsuno, Gen Sobue · 2018 · Journal of Movement Disorders
Parkinson's Disease Diagnosis via Joint Learning From Multiple Modalities and Relations
Haijun Lei, Zhongwei Huang, Feng Zhou, Ahmed Elazab, Ee-Leng Tan, Hancong Li, Jing Qin, Baiying Lei · 2018 · IEEE Journal of Biomedical and Health Informatics